Merck catalyst

Some chiral quaternary ammonium salts are also effective in Michael addition reactions. The Merck catalysts 7 (R=4-CF3, X=Br) and 9 (R=4-CF3, X=Br, 10,11-dihydro) were used tor the Michael additions of 59,61, and 64 to vinyl ketones to give the adducts 60,62, and 65 (isolated as 66), respectively,148,491 with excellent enantioselectivity, as shown in Scheme 19. The Michael addition of the O Donnell imine 23 to the a,(3-unsaturated carbonyl compounds also efficiently proceeded by use of the N-anthracenyl-methyl catalyst 12 (R=allyl, X=Br), giving the Michael adducts 67 (Scheme 20).1251... 

The cyclic a-chloro ketone 81 which forms the (Z)-enolate only also underwent the asymmetric Darzens condensation with various aldehydes by use of the Merck catalyst 7 (R=4-CF3, X=Br) under analogous conditions to furnish the a,(3-epoxy ketones 82 with up to 86 % ee,160611 as shown in Scheme 25. It should be noted that this high enantioselectivity was attained by the reaction at room temperature. 

Asymmetric a-hydroxylation of ketones 97 through phase transfer catalysis under alkaline conditions was realized by use of the Merck catalyst 7 (R=4-CF3, X=Br)[721 as well as the chiral azacrown ether 98[731 in conjunction with molecular oxygen, as shown in Scheme 30. The highest enantioselectivity of 79% ee was attained in the a-hydroxylation of the tetralone 100 by use of the Merck cata-... 

The catalyst, 3-benzyl-5-(2-hydroxyethyl )-4-methyl-l, 3-thiazoHum chloride, is supplied by Fluka AG, Buchs, Switzerland, and by Tridom Chemical, Inc., Hauppauge, New York. The thiazolium salt may also be prepared as described below by benzylation of 5-(2-hydroxyethyl)-4-methyl-l,3-thiazole which is commercially available from E. Merck, Darmstadt, West Germany, and Columbia Organic Chemicals Co., Inc., Columbia, SC. The acetonitrile used by the checkers was dried over Linde 3A molecular sieves and distilled under nitrogen, bp 77-78°C. The same yield of thiazolium salt was obtained by the checkers when benzyl chloride and acetonitrile from commercial sources were used without purification. 

The diazo function in compound 4 can be regarded as a latent carbene. Transition metal catalyzed decomposition of a diazo keto ester, such as 4, could conceivably lead to the formation of an electron-deficient carbene (see intermediate 3) which could then insert into the proximal N-H bond. If successful, this attractive transition metal induced ring closure would accomplish the formation of the targeted carbapenem bicyclic nucleus. Support for this idea came from a model study12 in which the Merck group found that rhodi-um(n) acetate is particularly well suited as a catalyst for the carbe-noid-mediated cyclization of a diazo azetidinone closely related to 4. Indeed, when a solution of intermediate 4 in either benzene or toluene is heated to 80 °C in the presence of a catalytic amount of rhodium(n) acetate (substrate catalyst, ca. 1000 1), the processes... 

Shoebox-sized lab-on-a-chip laboratories personal dmg manufacture general advantages of micro flow Merck s production nitrations HTS parallel catalyst testing turnkey bench-scale test station standardization cube-like modules [210],... 

P 21 ] Palladium on alumina was employed as catalyst [26]. Hydrogen and organic reactant were mixed in the micro mixer and fed to a Merck Superformance HPLC column of 100 mm length and 5 mm inner diameter, which was used as a hydrogenator. No further details are given in [67] or [26]. 

It is worth mentioning that both the carboxylation of epoxides and anilines are acid-base reactions, which do not entail redox processes. Therefore a catalyst active in these reactions must provide acid-base functionality. In this perspective, positively charged gold could be the real player, although a co-catalytic or promotion effect of ze-rovalent gold could also be important. Therefore the catalysts for the oxidative carbonylation of aniline, supported on Merck Ion-exchanger IV, could be actually bifunctional. On one side, Au could catalyze the oxidation of CO with O2 to CO2, a reaction for which it is... 

Chemicals and catalysts - Double distilled water was used in all experiments. Unless otherwise noted, chemicals were purchased from commercial companies and were used as received. Dodecanoic acid 98 wt% (GC), methanol, propanol and 2-ethylhexanol 99+ wt% were supplied by Aldrich, niobic acid by Companhia Brasileira de Metalurgia e Mineragao (CBMM), zirconil chloride octahydrate 98+ wt% by Acros Orgartics, 25 wt% NH3 solution and H2SO4 97% from Merck. Zeolites beta, Y and H-ZSM-5 were provided by Zeolyst, and ion-exchange resins by Alfa. 

Mo/HZSM-5 catalysts (3 wt% Mo nominal loading) were prepared by incipient wetness impregnation with an aqueous solution of ammonium heptamolybdate (Merck), drying at 100°C, and calcination at 500°C for 6 h. 

See, e.g., Dehmlov, E. V. Phasen Transfer Catalysts . MERCK-Schuchardt Darmstadt, Germany. 

Acknowledgements. The work on the development of transition metal catalysts described herein was funded by Degussa AG, Saltigo GmBH, Merck KGA, the BMBF, the FCI, the Alexander von Humboldt-Stiftung, the Max-Buchner-... 

A Ru-Josiphos catalyst was highly selective for the hydrogenation of an intermediate for an anthrax lethal factor inhibitor with a tetra-substituted C=C bond, as depicted in Figure 37.8 (Merck [44]). Rh-Josiphos (Lonza [42]) and Rh-Bo-Phoz (Eastman [45]) catalysts were effective for the hydrogenation of an exocy-clic and a cyclopropyl-substituted C=C bond. 

Further hydrogenations of a variety of C=C substrates depicted in Figure 37.22 range from a pilot process to several feasibility studies. Of special interest are PhanePhos, originally reported by Merck, an unsymmetrically substituted phos-pholane developed by Pfizer, and the rare case of an Ir-diphosphine complex active for the hydrogenation of a C=C bond. Nevertheless, the catalyst performances of most processes summarized in Figure 37.22 are probably not (yet) sufficient for manufacturing purposes. Indeed, several of the reports explicitly mention that further development was stopped, either because another route proved to be superior or because the compound was abandoned. 

Besides Ir-diphosphines, two more catalyst systems have shown promise for industrial application. As mentioned in Section 37.5.2, the Rh-Josiphos-cata-lyzed hydrogenation of unprotected /1-dehydro amino acid derivatives by Merck actually involves the hydrogenation of a C=N and not a C=C bond (see Fig. 37.10) [3, 51]. Noyori s Ru-PP-NN catalyst system seems also suitable for C=N hydrogenation [129], and was successfully applied in a feasibility study by Dow/Chirotech for the hydrogenation of a sulfonyl amidine [130]. Avecia also showed the viability of its CATHy catalyst for the transfer hydrogenation of phosphinyl imines [115] (see Fig. 37.34). 

Researchers at Merck Co. [35] who, together with scientists from Solvias, had developed the enantioselective hydrogenation of unprotected enamine amides and esters [36], reported a more recent example of product inhibition. The product amine amide or ester was found to be an inhibitor of the catalyst, and indeed instances of catalyst poisoning by amines have been reported several times (see later). The authors also found an excellent solution to this problem the addition of BOC-anhydride to the hydrogenation reaction neatly reacts away all the amine to form the BOC-protected amine, whereas the enamine was left unreacted (Scheme 44.4). This addition resulted in a remarkable rate enhancement [35]. 

The first practical and efficient asymmetric alkylation by use of chiral phase-transfer catalysts was the alkylation of the phenylindanone 15 (R1=Ph), reported by the Merck research group in 1984.114-161 By use of the quaternary ammonium salt 7 (R=4-CF3i X=Br) derived from cinchonine, the alkylated products 16 were obtained in excellent yield with high enantiomeric excess, as shown in... 

In Figure 13.19 we have shown a route to L-699,392 published by Merck involving three steps based on homogeneous catalysts, viz. two Heck reactions and one asymmetric hydrogen transfer reaction, making first an alcohol and subsequently a sulphide [21], Stoichiometric reductions for the ketone function have been reported as well [22] and the Heck reaction on the left-hand side can be replaced by a classic condensation reaction. L-699,392 is used in the treatment of asthma and related diseases. 

Merck-Schuchardt, Chiralica — Reagents, catalysts and building blocks for enantioselective synthesis Resolving Agents, E Merck Co., Germany, 1985. 

This procedure can be used to synthesize the key intermediate 34 of Merck s HIV protease inhibitor Crixivan 35 (Fig. 5) [25]. This reaction is done using dichloroacetaldehyde 26 instead of chloroacetaldehyde, forming the classical Ugi product 30. This intermediate is then treated with triethylamine to obtain the corresponding vinylchloride 31. Cyclization with KO Bu followed by stereoselective hydrogenation using the chiral catalyst Rh-BINAP afforded the Crixivan intermediate 34. (Scheme 5) The classical way to make this intermediate requires five steps, and thus makes the MCR route more attractive [25]. 

---